In this study, we sought to investigate the therapeutic potential and mechanism of action of an α7-nAChR PAM, PNU-120596, using a mouse tMCAO model, specifically examining whether PNU would modulate stroke-induced neurological dysfunction and neuropathology, with modulation of neuroinflammation as a possible mechanism. Here, CHRNA7 is linked to Stroke.